Miami-based Nicklaus Children’s Heart Institute is now performing bedside transcatheter patent ductus arteriosus (PDA) closures for newborns. The minimally invasive procedure is done directly in the ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

The bedside PDA closure program at Nicklaus Children's Heart Institute builds on the comprehensive spectrum of pediatric and congenital cardiac care, offering families in South Florida access to ...

While medications can close the PDA in about two-thirds of premature infants, the remaining third, as well as those requiring urgent closure, will still need a procedural intervention. Our aim is to ...

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...

Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...

One out of 10 of all babies are born premature. One in 10 babies are born premature and Irie Felkner and her twin brother, Judah Felkner, were two of them. Born 13 weeks prematurely, they were unable ...

New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...